Citation Impact
Citing Papers
“Intermittent claudication a real pain in the calf”—Patient experience of diagnosis and treatment with a supervised exercise program
2017 StandoutNobel
Quality of life in patients with intermittent claudication
2017 StandoutNobel
A Systematic Review of the Uptake and Adherence Rates to Supervised Exercise Programs in Patients with Intermittent Claudication
2016 StandoutNobel
Testosterone Therapy in Men with Androgen Deficiency Syndromes: An Endocrine Society Clinical Practice Guideline
2010 Standout
Medical Treatment of Peripheral Arterial Disease and Claudication
2001
Therapeutic Effects of l‐Carnitine and Propionyl‐l‐carnitine on Cardiovascular Diseases: A Review
2004
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2006 Standout
Comparative effects of cilostazol and other therapies for intermittent claudication
2001
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Regulation of myocardial carbohydrate metabolism under normal and ischaemic conditions Potential for pharmacological interventions
1997
Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis
2010 Standout
Disease-specific quality of life assessment in intermittent claudication: Review
2003
Endothelial dysfunction in peripheral arterial disease is related to increase in plasma markers of inflammation and severity of peripheral circulatory impairment but not to classic risk factors and atherosclerotic burden
2003
Cell Biology of Ischemia/Reperfusion Injury
2012 Standout
A Patient‐Derived Perspective of Health‐Related Quality of Life With Peripheral Arterial Disease
2002
Nutraceuticals, Vitamins, Antioxidants, and Minerals in the Prevention and Treatment of Hypertension
2005
2007 Guidelines for the Management of Arterial Hypertension
2007 Standout
European multicenter study on propionyl-L-carnitine in intermittent claudication
1999
Cardiovascular and musculoskeletal response to supervised exercise in patients with intermittent claudication
2018 StandoutNobel
Progression of Atherosclerosis in Patients with Peripheral Arterial Disease as a Function of Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism
2002
Myocardial Substrate Metabolism in the Normal and Failing Heart
2005 Standout
Diabetes and Atherosclerosis
2002 Standout
Extracorporeal Shockwave Therapy for Peripheral Arterial Disease: A Review of the Potential Mechanisms of Action
2017 StandoutNobel
Phosphorus 31 nuclear magnetic resonance spectroscopy suggests a mitochondrial defect in claudicating skeletal muscle
2000
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Assessment of Generic Health-related Quality of Life in Patients with Intermittent Claudication
2000
A systematic review of muscle morphology and function in intermittent claudication
2017 StandoutNobel
Quality of Life and Peripheral Arterial Disease
2006
Mitochondria and cardioprotection
2007
Relationship between health status and utility measures in older claudicants
1997
Effect of Propionyl-L-carnitine on a Background of Monitored Exercise in Patients With Claudication Secondary to Peripheral Artery Disease
2011
Correlation between ankle-brachial index, symptoms, and health-related quality of life in patients with peripheral vascular disease
2004
A Systematic Review of Extracorporeal Shockwave Therapy as a Novel Treatment for Intermittent Claudication
2016 StandoutNobel
Pharmacological Management of Intermittent Claudication
2000
Carnitine versus androgen administration in the treatment of sexual dysfunction, depressed mood, and fatigue associated with male aging
2004
Value of a supervised exercise program for the therapy of arterial claudication
1997
2021 Guideline for the Prevention of Stroke in Patients With Stroke and Transient Ischemic Attack: A Guideline From the American Heart Association/American Stroke Association
2021 Standout
Long-term outcomes of a randomized clinical trial of supervised exercise, percutaneous transluminal angioplasty or combined treatment for patients with intermittent claudication due to femoropopliteal disease
2016 StandoutNobel
Nutritional therapy for peripheral arterial disease: a double-blind, placebo-controlled, randomized trial of HeartBar®
2000
The intermittent claudication questionnaire: A patient-assessed condition-specific health outcome measure
2002
ACC/AHA 2005 Practice Guidelines for the Management of Patients With Peripheral Arterial Disease (Lower Extremity, Renal, Mesenteric, and Abdominal Aortic)
2006 Standout
Acquired skeletal muscle metabolic myopathy in atherosclerotic peripheral arterial disease
2000
Bioactive compounds in seaweed: functional food applications and legislation
2011 Standout
Myocardial Fatty Acid Metabolism in Health and Disease
2010 Standout
Current and Future Drug Therapies for Claudication
1997
Randomized clinical trial of percutaneous transluminal angioplasty, supervised exercise and combined treatment for intermittent claudication due to femoropopliteal arterial disease
2011
Exercise as medicine – evidence for prescribing exercise as therapy in 26 different chronic diseases
2015 Standout
Epidemiology of Peripheral Artery Disease
2015 Standout
Levo-Propionyl-Carnitine Improves the Effectiveness of Supervised Physical Training on the Absolute Claudication Distance in Patients With Intermittent Claudication
2008
A Review of the Potential Local Mechanisms by Which Exercise Improves Functional Outcomes in Intermittent Claudication
2015
Access to supervised exercise services for peripheral vascular disease patients
2017 StandoutNobel
Exercise training and peripheral vascular disease
2000
The Vascular Endothelium and Human Diseases
2013 Standout
Changes in Energy Metabolism of Calf Muscle in Patients with Intermittent Claudication Assessed by 31P Magnetic Resonance Spectroscopy: A Phase II Open Study
1996
Works of Sergio Perna being referenced
Propionyl-l-carnitine in intermittent claudication: Double-blind, placebo-controlled, dose titration, multicenter study
1995
Effect of Propionyl-L-Carnitine on Quality of Life in Intermittent Claudication
1997
Incidence, diagnostic methods, and evolution of left ventricular thrombus in patients with anterior myocardial infarction and low left ventricular ejection fraction: a prospective multicenter study
2015
Effect of L-Carnitine on the Reactive Hyperemia in Patients Affected by Peripheral Vascular Disease: A Double-Blind, Crossover Study
1989
Carnitine-Related Alterations in Patients With Intermittent Claudication
1996
Quality of Life in Patients with Intermittent Claudication: Relationship with Laboratory Exercise Performance
1996
Intermittent Claudication and Risk of Cardiovascular Events
1998